Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 17
Submit an article Journal homepage
135
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure

Jacob George Ninewells Hospital, Department of Clinical Pharmacology, Level 7, Dundee DD1 9SY, Scotland, UK +44 1382 660111; +44 1382 644972; [email protected]
, MB ChB MRCP &
Allan D Struthers Ninewells Hospital, Department of Clinical Pharmacology, Level 7, Dundee DD1 9SY, Scotland, UK +44 1382 660111; +44 1382 644972; [email protected]
, MD FRCP
Pages 3053-3059 | Published online: 15 Nov 2007

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Revathy Carnagarin, Vance Matthews, Cynthia Gregory & Markus P. Schlaich. (2018) Pharmacotherapeutic strategies for treating hypertension in patients with obesity. Expert Opinion on Pharmacotherapy 19:7, pages 643-651.
Read now
Massimo Volpe & Giuliano Tocci. (2010) Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice. Expert Review of Cardiovascular Therapy 8:6, pages 811-820.
Read now
David W Laight. (2009) Therapeutic inhibition of the renin angiotensin aldosterone system. Expert Opinion on Therapeutic Patents 19:6, pages 753-759.
Read now

Articles from other publishers (8)

. (2013) Individualized treatment with multiple antihypertensive agents is often necessary when treating hypertension in obese patients. Drugs & Therapy Perspectives 30:1, pages 21-25.
Crossref
Srividya Kidambi & Theodore A. Kotchen. (2013) Treatment of Hypertension in Obese Patients. American Journal of Cardiovascular Drugs 13:3, pages 163-175.
Crossref
Gary E. Sander & Thomas D. Giles. (2011) Resistant Hypertension: Concepts and Approach to Management. Current Hypertension Reports 13:5, pages 347-355.
Crossref
M. Bohm, J. C. Reil, P. Bramlage, B. Pitt & F. Zannad. (2011) Clinical efficacy of aldosterone-blocking agents. European Heart Journal Supplements 13:Suppl B, pages B36-B39.
Crossref
Katerina Leftheris, Yajun Zheng & Deepak S. Lala. 2011. 89 102 .
Jürgen Sandow. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 489 521 .
Daniel LaSala, Yasuhiko Shibanaka & Arco Y. Jeng. (2009) Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors. Analytical Biochemistry 394:1, pages 56-61.
Crossref
Tsuyoshi Isaka, Keiichi Ikeda, Yuko Takada, Yuri Inada, Katsuyoshi Tojo & Naoko Tajima. (2009) Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R. European Journal of Pharmacology 605:1-3, pages 49-52.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.